Gain A New Perspective on Your Clinical Research

Will you be at DIA 2017? Join us!

In its 53rd year, DIA 2017 promises to bring more than 7,000 global healthcare professionals from more than 51 countries to Chicago. Worldwide Clinical Trials will be part of the excitement – with more than 160 sessions in over 10+ tracks. One of our very own patient recruitment and engagement experts – Barbara Zupancic – will join a panel discussion to share best practices. And Barbara won’t be the only Worldwide expert on hand – our medical, scientific and operational experts will be at DIA 2017 to attend sessions, share ideas, and network throughout the event.

We also plan to delight qualified visitors to our Worldwide Clinical Trials booth with another fantastic give-away (we ran out in the first day of the show in 2016!). For your opportunity to meet with one of our experts, and reserve your give-away, please request a meeting with a member of our business development team. You’ll receive your give-away at the meeting, and learn how Worldwide can help maximize the success of your clinical research projects. 

Schedule a meeting today, and visit us at Booth #1316!

Patient Recruitment & Engagement Panel Session
Barbara Zupancic – Worldwide Clinical Trials Global Director of Patient Recruitment and Retention

In a panel session at DIA 2017, Barbara Zupancic will join other experts to discuss challenges around patient recruitment and retention. Barbara will lend her expertise to the panel, sharing best practices for developing and implementing a patient-centered approach that is focused on using the right communications channels and messaging for faster recruitment and lasting engagement.

Barbara has more than ten years of experience in clinical research, specifically focused on patient recruitment and feasibility. She is passionate about engaging patient volunteers to improve lives and has spent countless hours in the field working with a wide range of research sites and patient groups. Barbara has a BS in psychology, MS in Counseling Psychology & Research, and an MBA in management.

DON’T MISS THE SESSION
Monday, 19 June | 11:00AM CT

Seats for this panel are limited! Express your interest by completing the form on the right.
Check out our TOP SPOTS to visit in Chicago!

Similar to how we anticipate our customers’ needs with their clinical research programs, we thought you could use some ideas for how to make the most of your visit to Chicago. We created our Chicago Survival Guide to help you uncover the most memorable places to see and experience during your stay in this amazing city.

Michael F. Murphy, MD, PhD
Chief Medical and Scientific Officer

While individually rare, orphan diseases are actually collectively common, with an estimated 350 million sufferers worldwide. Since the introduction of the US Orphan Drug Act more than 30 years ago, the number of orphan designations has skyrocketed and experts are predicting worldwide sales of these drugs will reach $176 billion by the end of 20201. With the cost of developing orphan drugs comparatively less than non-orphan products, appreciable regulatory support for innovative program design, and with the possibility of demonstrating significant intellectual property value, interest and investment in orphan disease development programs has been explosive.

Read More

Schedule a Meeting: